Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Valenta Pharm, formerly known as Otechestvennye Lekarstva, is a prominent Russian pharmaceutical company dedicated to the development, production, and marketing of innovative and generic medicinal products. Founded in 1997, the company underwent a significant rebranding in 2008 to consolidate its manufacturing assets and strengthen its market presence. Valenta Pharm focuses on high-growth therapeutic areas including virology, psychoneurology, gastroenterology, and immunology. Its portfolio includes market-leading brands such as the antiviral Ingavirin and the antimicrobial Grammidin. The company operates a sophisticated, GMP-certified manufacturing facility in Shchelkovo, which supports its mission of providing high-quality, accessible healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Otechestvennye Lekarstva.